Evolent Health (EVH) | Stock Overview & Key Data
Evolent Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $39.78 on September 12, 2022
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Evolent Health
EVH
|
329.33M Small-cap | 0.86% | 18.69% | 55.63% | 14.08% | 20.82% | -41.96% | -83.22% | -75.66% | -70.50% | -74.55% | -74.55% |
|
Ge Healthcare
GEHC
|
31.89B Large-cap | 0.14% | 6.58% | -10.27% | -23.32% | -21.81% | -9.79% | -17.13% | 14.87% | 14.87% | 14.87% | 14.87% |
|
Veeva Systems
VEEV
|
26.49B Large-cap | -3.03% | 2.08% | -12.47% | -26.32% | -26.12% | -43.54% | -20.25% | -47.98% | 374.26% | 259.41% | 259.41% |
|
Omnicell
OMCL
|
1.65B Small-cap | -4.67% | -7.26% | 16.62% | -7.58% | -11.41% | 29.33% | -47.23% | -73.67% | 16.01% | 151.70% | 181.05% |
|
Teladoc Health
TDOC
|
1.04B Small-cap | 5.37% | 17.30% | 38.40% | 1.63% | 5.82% | 7.00% | -70.52% | -95.30% | -42.92% | -73.79% | -73.79% |
|
Certara
CERT
|
969.01M Small-cap | -0.19% | 16.29% | -19.72% | -40.39% | -40.39% | -52.77% | -70.03% | -81.17% | -86.34% | -86.34% | -86.34% |
Ownership & Short Interest
Calculate Your Evolent Health Investment Returns
Long-Term Investment Performance Analysis
Evolent Health stock price in Jul 2016 was $23.99, A $1,000.00 lump sum investment in Evolent Health made 9 years ago would be worth approximately $195.91 today, representing a negative return of -80.41%. This translates to an annualized return (CAGR) of -15.17%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is EVH's 52-week high and low?
- In the last 52 weeks, Evolent Health reached a high of $12.06 (on July 7, 2025) and a low of $2.10 (on April 2, 2026).
- What is the market cap and P/E ratio for EVH?
- Curious about Evolent Health's size and valuation? Its market capitalization stands at 329.33M. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.58, and the forward P/E (looking ahead) is 7.13.
- Does EVH pay dividends? If so, what's the yield?
- As for dividends, Evolent Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Evolent Health's main competitors or similar companies to consider before investing?
When looking at Evolent Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Ge Healthcare
GEHC31.89B Healthcare Health Information Services -9.79% -17.13% Veeva Systems
VEEV26.49B Healthcare Health Information Services -43.54% -20.25% Omnicell
OMCL1.65B Healthcare Health Information Services 29.33% -47.23% Teladoc Health
TDOC1.04B Healthcare Health Information Services 7.00% -70.52% Certara
CERT969.01M Healthcare Health Information Services -52.77% -70.03% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Evolent Health Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Evolent Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -66.54%, the Debt to Equity ratio from the most recent quarter is 238.37, and its Gross Profit Margin stands at 20.75%.
- What is the recent revenue and earnings growth for EVH?
- Looking at Evolent Health's growth, its revenue over the trailing twelve months (TTM) was $2B. Compared to the same quarter last year (YoY), quarterly revenue grew by -27.50%, and quarterly earnings saw a YoY growth of N/A.
- How much of EVH stock is held by insiders and institutions?
- Wondering who owns Evolent Health stock? Company insiders (like executives and directors) hold about 1.62% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 110.52%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.